Darya-Varia Laboratoria
Corporate brand
UnclaimedPT Darya-Varia Laboratoria Tbk is an Indonesian pharmaceutical company listed on the Indonesia Stock Exchange under the ticker DVLA.
Last updated September 15, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
PT Darya-Varia Laboratoria Tbk ("Darya-Varia" or "the Company") is a domestic investment pharmaceutical company established in 1976 and headquartered in Jakarta, Indonesia. In November 1994 it listed its shares on the Indonesia Stock Exchange under the ticker code DVLA. In 1995 it acquired PT Pradja Pharin (Prafa) and became the parent entity to continue expanding into the health sector in Indonesia; in 2014 the Company merged with Prafa, with Darya-Varia as the sole surviving entity. It operates two manufacturing plants meeting c-GMP and BPOM standards, and collaborates with affiliated company PT Medifarma Laboratories for toll manufacturing.
History
PT Darya-Varia Laboratoria Tbk is a domestic investment pharmaceutical company established in 1976. In November 1994, Darya-Varia listed its shares on the Indonesia Stock Exchange (IDX) with the stock ticker code of DVLA. In 1995, Darya-Varia acquired PT Pradja Pharin (Prafa) and became the parent entity to continue expanding into the health sector in Indonesia. In 2014, the Company merged with Prafa, with Darya-Varia as the sole surviving entity. The Company operates two manufacturing plants that have met the international standards of current Good Manufacturing Practice (c-GMP) and standards set by the National Agency of Drug and Food Control (BPOM).
Products and positioning
A pharmaceutical company with a mission to build a healthier Indonesia, emphasizing strong brands and quality products trusted and well-known in Indonesia.
Soft gelatin capsule products, liquid preparations, medicinal plasters, ointments, and creams
Sterile injection products and solid preparations in the form of tablets and capsules
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/darya-varia-laboratoria · Editorial policy · How profiles are compiled